{"certainAgreement":{"otherDetails":"The investigator has the right to independently publish study results from the investigator's site after a multi-center publication, or a defined period after the completion of the study by all sites. The investigator must provide the Sponsor a copy of any such publication derived from the study for review and comment in advance of any submission, and delay publication, if requested, to allow the Sponsor to preserve its proprietary rights.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrials@regeneron.com","organization":"Regeneron Pharmaceuticals, Inc.","phone":"844-734-6643","title":"Clinical Trials Administrator"}}